Oligonucleotides with Iodo-Substituted Aglycons
extracted with ethyl acetate. The combined organic layer was
washed with saturated aq NaHCO3 water and brine. The solution
was dried over anhydrous Na2SO4 and evaporated under reduced
pressure. The residue was purified by silica gel column chroma-
tography (C-200, 100 g, hexane/ethyl acetate, 0-1%) to give
anomeric mixture 8 (1.80 g, 32%, R/â ) 1:5.6). 1H NMR (CDCl3,
500 MHz) δ 7.73 (0.15H, s), 7.68 (0.85H, s), 7.60-7.58 (1H, m),
7.30-7.29 (1H, m), 7.07-7.04 (1H, m), 5.02 (0.85H, t, J ) 7.33
Hz), 4.96 (0.15H, dd, J ) 6.10, 9.77 Hz), 4.59-4.54 (0.15H, m),
4.52-4.48 (0.85H, m), 4.14-4.10 (0.85H, m), 4.07-4.03 (0.15H,
m), 3.93-3.86 (2H, m), 2.67-2.62 (0.15H, m), 2.39-2.34 (0.85H,
m), 2.12-2.00 (1H, m), 1.12-0.95 (28H, m); 13C NMR (CDCl3,
126 MHz, â-isomer) δ 144.8, 136.7, 134.9, 130.3, 125.3, 94.7, 86.7,
78.3, 73.2, 63.7, 43.3, 17.8, 17.7, 17.7, 17.5, 17.3, 17.3, 17.2, 13.7,
J ) 24.95 Hz), 85.9, 72.9 (d, J ) 2.88 Hz), 72.3, 63.1, 41.9, 17.8,
17.7, 17.6, 17.5, 17.3, 17.3, 17.2, 13.7, 13.6, 13.2, 12.8. ESI MS
+
calcd C23H38F2NaO4Si2 [M + Na]+ 495.2169, found 495.2170.
1,2-Dideoxy-1-(2,4-difluoro-3-iodophenyl)-D-ribofuranose (19).
To a solution of an anomeric mixture of 18 (460 mg, 0.97 mmol)
in dry THF (10 mL) was added dropwise via a syringe s-BuLi (0.95
M in hexane, 1.13 mL, 1.07 mmol) under argon at -78 °C. The
mixture was stirred at -78 °C for 2 h and then added via a syringe
to a solution of iodine (272 mg, 1.07 mmol) in dry THF (550 µL).
The mixture was warmed to room temperature and stirred for 1 h.
The reaction was quenched by the addition of saturated aq Na2-
SO3. The resulting mixture was extracted with ethyl acetate-H2O.
The organic extracts were combined, dried over anhydrous Na2-
SO4, and concentrated under reduced pressure. The resulting oil
was used without further purification. A solution of the residue in
THF (5 mL) was treated with Et3N (251 µL, 1.80 mmol) and Et3N‚
3HF (570 µL, 3.50 mmol) at room temperature. After stirring for
6 h, the mixture was extracted with ethyl acetate-H2O, and the
organic layer was washed with saturated aq NaHCO3 and brine.
The organic extract was dried over anhydrous Na2SO4 and
evaporated under reduced pressure. The residue was purified by
silica gel column chromatography (C-200, 30 g, CHCl3/MeOH,
0-2%) to give an anomeric mixture of 19 as a colorless oil (301
mg, 87%). 1H NMR (DMSO-d6, 500 MHz, â-isomer) δ 7.61 (1H,
dd, J ) 8.54, 15.13 Hz), 7.13 (1H, t, J ) 7.56 Hz), 5.20 (1H, dd,
J ) 5.61, 10.25 Hz), 5.12 (1H, d, J ) 3.90 Hz), 4.78 (1H, t, J )
5.86 Hz), 4.20-4.18 (1H, m), 3.81-3.74 (1H, m), 3.50-3.40 (2H,
m), 2.14-2.11 (1H, m), 1.80-1.74 (1H, m); 13C NMR (DMSO-
d6, 126 MHz, â-isomer) δ 161.2 (dd, J ) 6.72, 242.81 Hz), 158.7
(dd, J ) 6.72, 244.24 Hz), 128.6 (dd, J ) 3.84, 16.32 Hz), 111.5
(dd, J ) 2.88, 12.00 Hz), 87.7, 72.9, 72.4 (t, J ) 30.71 Hz), 72.2,
13.6, 13.2, 12.8. ESI MS calcd C23H43INO4Si2 [M + NH4]+
+
580.1770, found 580.2539.
1,2-Dideoxy-1-(3-iodophenyl)-D-ribofuranose (9). To a solution
of an R,â-anomeric mixture of 8 (1.68 g, 3.18 mmol) in THF (16
mL) were added Et3N (799 µL, 5.73 mmol) and Et3N‚3HF (1.81
mL, 11.2 mmol) at room temperature. After stirring for 1 h, the
mixture was extracted with CHCl3-H2O, and the organic layer was
washed with H2O. The organic solution was dried over anhydrous
Na2SO4 and evaporated under reduced pressure. The residue was
purified by silica gel column chromatography (C-200, 30 g, CHCl3/
MeOH, 0-3%) to give an anomeric mixture of 9 as a colorless oil
(951 mg, quant., R/â ) 1:5.6). 1H NMR (CDCl3, 500 MHz) δ 7.74
(0.15H, s), 7.70 (0.85H, s), 7.63-7.60 (1H, m), 7.33-7.29 (1H,
m), 7.10-7.05 (1H, m), 5.10 (0.85H, dd, J ) 5.62, 10.26 Hz), 5.38
(0.15H, t, J ) 7.81 Hz), 4.47-4.42 (1H, m), 4.07 (0.15H, dd, J )
4.88, 9.28 Hz), 4.02-4.00 (0.85H, m), 3.85-3.81 (1H, m), 3.78-
3.71 (1H, m), 2.70-2.65 (0.15H, m), 2.28-2.65 (0.85H, m), 2.04-
1.94 (3H, m); 13C NMR (CDCl3, 126 MHz, â-isomer) δ 143.7,
136.9, 135.0, 130.4, 125.4, 94.6, 87.5, 79.3, 73.6, 63.4, 43.9. ESI
+
62.2, 42.0. ESI MS calcd C11H11F2INaO3 [M + Na]+ 378.9613,
found 378.9607.
MS calcd. C11H13INaO3 [M + Na]+ 342.9802, found 342.9808.
1-[2-Deoxy-3,5-di-O-(4-toluoyl)-â-D-ribofuranose-1-yl]-4,5-di-
iodoimidazole (31). To a solution of 4,5-diiodoimidazole (29) (2.22
g, 6.95 mmol) in dry acetonitrile (70 mL) was added sodium hydride
(167 mg, 6.95 mmol). After the mixture had been stirred at room
temperature for 30 min, 1-chloro-2-deoxy-3,5-di-O-p-toluoyl-R-D-
erythro-pentofuranose (30) (500 mg × 4, 6.32 mmol) was added
in four portions at 15 min intervals. After a total 2 h of stirring,
the solvent was evaporated under reduced pressure. The residue
was diluted with ethyl acetate (200 mL). The organic solution was
washed with H2O (200 mL) and dried over anhydrous Na2SO4. The
solvent was evaporated under reduced pressure, and the residue
was purified by silica gel colum chromatography using a gradient
(0-12%) of CHCl3/hexane to give 31 (3.80 g, 89%) as a white
+
3,5-O-[(1,1,3,3-Tetra-isopropyl)disiloxanediyl]-1,2-dideoxy-1-
(2,4-difluorophenyl)-D-ribofuranose (18). Magnesium (384 mg,
15.8 mmol) and iodine (200 mg, 0.79 mmol) were added to dry
THF (15 mL) under argon at room temperature. 2,4-Difluorobro-
mobenzene (15) (1.89 mL, 15.8 mmol) was added dropwise via a
syringe to the mixture. The mixture was stirred for 1 h at room
temperature. After formation of the Grignard reagent 16 was
complete, 3,5-O-[(1,1,3,3-tetra-isopropyl)disiloxanediyl]-2-deoxy-
D-ribono-1,4-lactone (6) (2.00 g, 5.27 mmol) in dry THF (5 mL)
was added via a syringe to the mixture at 0 °C. After stirring for
2 h, the reaction mixture was quenched with saturated aq NH4Cl
and extracted with ethyl acetate. The combined organic layer was
washed with saturated aq NH4Cl, water, and brine. The organic
solution was dried over anhydrous Na2SO4 and concentrated under
reduced pressure. The resulting oil containing the hemiacetal 17
was used without further purification in the next reaction. A solution
of the crude oil in CH2Cl2 (15 mL) under argon at -78 °C was
treated with Et3SiH (2.53 mL, 15.8 mol) and BF3‚OEt2 (2.00 mL,
15.8 mmol). The resulting solution was stirred at -78 °C for 6 h,
and the reaction was quenched by the addition of saturated aq
NaHCO3 at -78 °C. The resulting mixture was extracted with ethyl
acetate. The combined organic layer was washed with saturated aq
NaHCO3, water, and brine. The solution was dried over anhydrous
Na2SO4 and evaporated under reduced pressure. The residue was
purified by silica gel column chromatography (C-200, 80 g, hexane/
ethyl acetate, 0-1%) to give an anomeric mixture of 18 (627 mg,
25%, R/â ) 1:6.7). 1H NMR (CDCl3, 500 MHz) δ 7.51-7.47 (1H,
m), 6.86-6.82 (1H, m), 6.79-6.75 (1H, m), 5.28 (0.86H, t, J )
7.32 Hz), 5.21 (0.14H, dd, J ) 6.09, 9.64 Hz), 4.59-4.54 (0.14H,
m), 4.09 (0.86H, dd, J ) 5.86, 13.43), 4.13-4.04 (1H, m), 3.95-
3.83 (2H, m, Râ-5H), 2.74-2.69 (0.14H, m), 2.46-2.41 (0.86H,
m), 2.07-2.02 (1H, m), 1.13-0.92 (28H, m); 13C NMR (CDCl3,
126 MHz, â-isomer) δ 162.5 (dd, J ) 12.48, 247.60 Hz), 159.8
(dd, J ) 12.48, 249.52 Hz), 128.3 (dd, J ) 6.72, 9.60 Hz), 126.0
(dd, J ) 3.84, 13.44 Hz), 111.3 (dd, J ) 3.84, 21.11 Hz), 103.8 (t,
1
solid. H NMR (CDCl3, 500 MHz) δ 7.95-7.85 (5H, m), 7.29-
7.23 (4H, m), 6.78 (1H, dd, J ) 5.62, 7.81 Hz), 5.64 (1H, m),
4.67, (2H, t, J ) 2.69, 3.42 Hz), 4.61 (1H, m), 2.81-2.80 (1H, m),
2.58-2.53 (1H, m), 2.44 (3H, s), 2.41 (3H, s); 13C NMR (CDCl3,
126 MHz) δ 166.3, 166.0, 144.8, 144.5, 139.1, 130.0, 129.7, 129.6,
129.5, 126.6, 126.4, 97.3, 89.6, 83.3, 79.8, 74.7, 63.9, 39.9, 21.9,
+
21.9. ESI MS calcd C24H23I2N2O5 [M + H]+ 672.9696, found
672.9682.
1-(2-Deoxy-â-D-ribofuranose-1-yl)-4,5-diiodoimidazole (32).
To a solution of 31 (3.79 g, 5.46 mmol) in MeOH (56 mL) was
added NaOMe (305 mg, 5.46 mmol). After this, the mixture was
stirred at room temperature for 1 h. The mixture was purified by
dry silica gel column chromatography (C-200, 80 g, methanol/
1
chloroform, 0-3%) to give 32 (2.21 g, 90%) as a white solid. H
NMR (DMSO-d6, 500 MHz) δ 8.14 (1H, s), 5.88 (1H, t, J ) 6.59
Hz), 5.34 (1H, d, J ) 4.15 Hz), 4.95 (1H, t, J ) 5.13 Hz), 4.30-
4.28 (1H, m), 3.83-4.82 (1H, m), 3.54-3.45 (2H, m), 2.41-2.27
(2H, m); 13C NMR (DMSO-d6, 126 MHz) δ 140.1, 97.2, 88.6, 88.0,
+
84.4, 70.3, 61.2, 40.3. ESI MS calcd C8H11I2N2O3 [M + H]+
436.8859, found 436.8845.
1-[2-Deoxy-5-O-(4,4′-dimethoxytrityl)-â-D-ribofuranose-1-yl]-
4,5-diiodoimidazole (33). The free nucleotide 32 (2.18 g, 5.00
mmol) was dried by coevaporation with dry pyridine (2 mL × 3)
J. Org. Chem, Vol. 73, No. 2, 2008 389